Alexandria Venture Investments, LLC is > 10% Shareholder of Xilio Therapeutics, Inc.. Currently has a direct ownership of 166,423 shares of XLO, which is worth approximately $211,357. The most recent transaction as insider was on Oct 26, 2021, when has been sold 166,423 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K
0% 3M change
0% 12M change
Total Value Held $211,357

Alexandria Venture Investments, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 26 2021
BUY
Conversion of derivative security
-
166,423 Added 50.0%
166,423 Common Stock

Also insider at

SBTX
Silverback Therapeutics, Inc. Healthcare
VOR
Vor Biopharma Inc. Healthcare
OMIC
Singular Genomics Systems, Inc. Healthcare
VIGL
Vigil Neuroscience, Inc. Healthcare
AVI

Alexandria Venture Investments, LLC

> 10% Shareholder
Pasadena, CA

Track Institutional and Insider Activities on XLO

Follow Xilio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLO shares.

Notify only if

Insider Trading

Get notified when an Xilio Therapeutics, Inc. insider buys or sells XLO shares.

Notify only if

News

Receive news related to Xilio Therapeutics, Inc.

Track Activities on XLO